China Plant Sterol Trial
Hypercholesterolemia, Cardiovascular Diseases
About this trial
This is an interventional prevention trial for Hypercholesterolemia focused on measuring Phytosterols, Cholesterol, China, Randomized controlled trial
Eligibility Criteria
Inclusion Criteria: The key inclusion criteria will be: Age between 18 and 65 years old (inclusive) at baseline Able to provide informed consent Usual diet that includes significant fat consumption at the main meals eaten each week and/or a history of hypercholesterolemia Participant is likely to comply with the study treatment during the study period Exclusion Criteria: Participants will be excluded on the basis of: Known serious gastrointestinal disease or other serious illness. Individuals with stable cardiovascular disease will, however, be eligible Known lactose intolerance or diet that excludes dairy products Known Sitosterolaemia (a very rare genetic condition causing very high blood sitosterol levels) Current hospitalisation Current use of drug with likely significant impact on gastro-intestinal absorption of cholesterol or plant sterol (e.g. ezetimibe, bile acid-binding resins, or orlistat) Participant is currently using or is planning to use non-trial plant sterol/stanol-containing products for the seven week study period Participation in another study within last 3 months Pregnant or planning to become pregnant in next three months
Sites / Locations
- Peking University Health Science Centre